Aurinia snags FDA approval for lupus nephritis med Lupkynis, its first drug launch

Aurinia snags FDA approval for lupus nephritis med Lupkynis, its first drug launch

Source: 
Fierce Pharma
snippet: 

Aurinia has nabbed its first FDA approval with an OK for Lupkynis (voclosporin) to treat lupus nephritis, or kidney inflammation caused by systemic lupus erythematosus. And now it'll look to its newly bolstered commercial team to take the drug into a wide-open market.